Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value: $414M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS INC | 1,300,000 | $29.47M | 7.1% | $21.47 | -9.0% | COM | 30161Q104 |
| XENE | XENON PHARMACEUTICALS INC | 920,000 | $28.12M | 6.8% | $20.67 | +44.8% | COM | 98420N105 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,010,000 | $26.03M | 6.3% | $25.28 | +5.0% | COM | 89422G107 |
| BCYC | BICYCLE THERAPEUTICS PLC | 550,592 | $24.16M | 5.8% | $50.05 | — | SPONSORED ADS | 088786108 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 155,000 | $24.13M | 5.8% | $145.12 | 0.0% | SHS USD | G50871105 |
| CYTK | CYTOKINETICS INC | 650,000 | $23.93M | 5.8% | $32.25 | +10.2% | COM NEW | 23282W605 |
| — | CHINOOK THERAPEUTICS INC | 1,423,682 | $23.29M | 5.6% | $16.35 | — | COM | 16961L106 |
| GLPG | GALAPAGOS NV | 360,000 | $22.33M | 5.4% | $56.28 | — | SPON ADR | 36315X101 |
| VRTX | VERTEX PHARMACEUTICALS INC | 85,000 | $22.18M | 5.4% | $195.24 | +21.6% | COM | 92532F100 |
| PCVX | VAXCYTE INC | 885,153 | $21.38M | 5.2% | $22.75 | -4.0% | COM | 92243G108 |
| RLMD | RELMADA THERAPEUTICS INC | 790,000 | $21.32M | 5.2% | $22.09 | -6.4% | COM | 75955J402 |
| ANAB | ANAPTYSBIO INC | 700,000 | $17.32M | 4.2% | $25.71 | +17.7% | COM | 032724106 |
| — | POINT BIOPHARMA GLOBAL INC | 2,060,000 | $16.42M | 4.0% | $7.75 | — | COM | 730541109 |
| ACRS | ACLARIS THERAPEUTICS INC | 942,445 | $16.25M | 3.9% | $15.39 | -11.4% | COM | 00461U105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 874,197 | $12.89M | 3.1% | $15.10 | -4.8% | COM | 483497103 |
| — | RIGEL PHARMACEUTICALS INC | 4,000,000 | $11.96M | 2.9% | $3.25 | — | COM NEW | 766559603 |
| — | KINIKSA PHARMACEUTICALS LTD | 1,118,067 | $11.11M | 2.7% | $10.66 | — | COM CL A | G5269C101 |
| — | TRICIDA INC | 1,250,000 | $10.28M | 2.5% | $4.49 | — | COM | 89610F101 |
| RNAM | AVIDITY BIOSCIENCES INC | 500,000 | $9.235M | 2.2% | $23.88 | -28.9% | COM | 05370A108 |
| SLN | SILENCE THERAPEUTICS PLC | 444,443 | $8.444M | 2.0% | $23.89 | — | ADS | 82686Q101 |
| URGN | UROGEN PHARMA LTD | 873,424 | $7.608M | 1.8% | $15.60 | -50.0% | COM | M96088105 |
| — | PIERIS PHARMACEUTICALS INC | 2,199,076 | $6.663M | 1.6% | $3.56 | — | COM | 720795103 |
| ARDX | ARDELYX INC | 4,761,905 | $5.095M | 1.2% | $0.89 | 0.0% | COM | 039697107 |
| VTYX | VENTYX BIOSCIENCES INC | 336,334 | $4.564M | 1.1% | $13.36 | 0.0% | COM | 92332V107 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 928,282 | $3.63M | 0.9% | $5.44 | 0.0% | COM | 00509G209 |
| — | MAGENTA THERAPEUTICS INC | 1,170,000 | $3.393M | 0.8% | $9.65 | — | COM | 55910K108 |
| — | CINCOR PHARMA INC | 79,670 | $1.397M | 0.3% | $17.53 | — | COM | 17240Y109 |
| — | NEKTAR THERAPEUTICS | 100,000 | $539K | 0.1% | — | — | Call | 640268108 |
| — | PASSAGE BIO INC | 113,900 | $353K | 0.1% | $6.35 | — | COM | 702712100 |
| RFL | RAFAEL HLDGS INC | 121,000 | $304K | 0.1% | $45.91 | -92.5% | COM CL B | 75062E106 |